Ménière’s is characterized by recurrent episodes of vertigo, fluctuating hearing loss and tinnitus. It affects between 0. 3 and 1. 9 per 1,000 people. Other conditions that may produce similar symptoms include vestibular migraine and transient ischemic attack. Attacks are often treated with medications to help with the nausea and anxiety. Measures to prevent attacks are overall poorly supported by the evidence.
About Ménière’s disease in brief

The mechanism of MD is not fully explained by EH, but fully developed EH may mechanically and chemically interfere with the sensory cells for balance and hearing, which can lead to temporary dysfunction and even to death of the sensory Cells. People who have had a transient stroke or stroke can present with similar symptoms to MD, and in people at risk of a stroke or risk of TIA, magnetic resonance imaging should be conducted to exclude magnetic resonance resonance imaging or TIA or a stroke. The corresponding subtypes of MD are vestibial MD and cochlear MD, showing symptoms of hearing loss. In MAVV, hearing loss is usually in both ears, and this is rare in this condition. In MD, this is usually in both ears and it does not progress in many ways, but this is not rare in MAV-VVV. It is generally generally generally unexplained in MAV, but there are cases where it does progress in this way as it does in MD, generally in people who have vestibulopathy, schwannoma, or a recurrent unilateral vestibule tumor.
You want to know more about Ménière’s disease?
This page is based on the article Ménière’s disease published in Wikipedia (as of Dec. 30, 2020) and was automatically summarized using artificial intelligence.






